http://www.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2026, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Tue, 16 Jun 2026 08:15:00 -0400 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://www.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/Press+Releases/Fresh+Off+Its+Nasdaq+Debut%2C+a+Regenerative-Medicine+Upstart+Is+Stacking+Its+Board+With+Big-Pharma+Firepower/26650893.html <div class="xn-content"> <p><i>Issued on behalf of <span value="NASDAQ-NMS:CNXU" idsrc="xmltag.org" >Conexeu Sciences Inc.</span></i></p><p><i>A clutch of new directors with Fortune 500 finance, M&amp;A, and aesthetics pedigrees signals that the newly public tissue-regeneration company is building for commercialization — in one of medicine's most consequential frontiers.</i></p><p><span class="legendSpanClass">RENO, Nev.</span>, <span class="legendSpanClass"><chron>June 16, 2026</chron></span> /PRNewswire/ -- <a target="_blank" href="https://www.americannewsgroup.com/" target="_blank" rel="nofollow"><span>American News Group</span></a> News Commentary — There is a well-worn pattern in the life sciences: a company spends years on the science, goes public, and then — in the critical window right after listing — races to assemble the kind of leadership bench that can turn a http://www.streetinsider.com/Press+Releases/Fresh+Off+Its+Nasdaq+Debut%2C+a+Regenerative-Medicine+Upstart+Is+Stacking+Its+Board+With+Big-Pharma+Firepower/26650893.html Tue, 16 Jun 2026 08:15:00 -0400 2025 A.17530805 A.30162132 ABBV ABBV CNXU ESTA O.00384685 O.00391766 O.04998225 O.13747093 O.14731390 O.31243832 SN SNN SNN SYK SYK http://www.streetinsider.com/Press+Releases/Fresh+Off+Its+Nasdaq+Debut%2C+a+Regenerative-Medicine+Upstart+Is+Stacking+Its+Board+With+Big-Pharma+Firepower/26650893.html <div class="xn-content"> <p><i>Issued on behalf of <span value="NASDAQ-NMS:CNXU" idsrc="xmltag.org" >Conexeu Sciences Inc.</span></i></p><p><i>A clutch of new directors with Fortune 500 finance, M&amp;A, and aesthetics pedigrees signals that the newly public tissue-regeneration company is building for commercialization — in one of medicine's most consequential frontiers.</i></p><p><span class="legendSpanClass">RENO, Nev.</span>, <span class="legendSpanClass"><chron>June 16, 2026</chron></span> /PRNewswire/ -- <a target="_blank" href="https://www.americannewsgroup.com/" target="_blank" rel="nofollow"><span>American News Group</span></a> News Commentary — There is a well-worn pattern in the life sciences: a company spends years on the science, goes public, and then — in the critical window right after listing — races to assemble the kind of leadership bench that can turn a http://www.streetinsider.com/Press+Releases/Fresh+Off+Its+Nasdaq+Debut%2C+a+Regenerative-Medicine+Upstart+Is+Stacking+Its+Board+With+Big-Pharma+Firepower/26650893.html Tue, 16 Jun 2026 08:15:00 -0400 2025 A.17530805 A.30162132 ABBV ABBV CNXU ESTA O.00384685 O.00391766 O.04998225 O.13747093 O.14731390 O.31243832 SN SNN SNN SYK SYK http://www.streetinsider.com/Press+Releases/Fresh+Off+Its+Nasdaq+Debut%2C+a+Regenerative-Medicine+Upstart+Is+Stacking+Its+Board+With+Big-Pharma+Firepower/26650893.html <div class="xn-content"> <p><i>Issued on behalf of <span value="NASDAQ-NMS:CNXU" idsrc="xmltag.org" >Conexeu Sciences Inc.</span></i></p><p><i>A clutch of new directors with Fortune 500 finance, M&amp;A, and aesthetics pedigrees signals that the newly public tissue-regeneration company is building for commercialization — in one of medicine's most consequential frontiers.</i></p><p><span class="legendSpanClass">RENO, Nev.</span>, <span class="legendSpanClass"><chron>June 16, 2026</chron></span> /PRNewswire/ -- <a target="_blank" href="https://www.americannewsgroup.com/" target="_blank" rel="nofollow"><span>American News Group</span></a> News Commentary — There is a well-worn pattern in the life sciences: a company spends years on the science, goes public, and then — in the critical window right after listing — races to assemble the kind of leadership bench that can turn a http://www.streetinsider.com/Press+Releases/Fresh+Off+Its+Nasdaq+Debut%2C+a+Regenerative-Medicine+Upstart+Is+Stacking+Its+Board+With+Big-Pharma+Firepower/26650893.html Tue, 16 Jun 2026 08:15:00 -0400 2025 A.17530805 A.30162132 ABBV ABBV CNXU ESTA O.00384685 O.00391766 O.04998225 O.13747093 O.14731390 O.31243832 SN SNN SNN SYK SYK http://www.streetinsider.com/Press+Releases/Fresh+Off+Its+Nasdaq+Debut%2C+a+Regenerative-Medicine+Upstart+Is+Stacking+Its+Board+With+Big-Pharma+Firepower/26650893.html <div class="xn-content"> <p><i>Issued on behalf of <span value="NASDAQ-NMS:CNXU" idsrc="xmltag.org" >Conexeu Sciences Inc.</span></i></p><p><i>A clutch of new directors with Fortune 500 finance, M&amp;A, and aesthetics pedigrees signals that the newly public tissue-regeneration company is building for commercialization — in one of medicine's most consequential frontiers.</i></p><p><span class="legendSpanClass">RENO, Nev.</span>, <span class="legendSpanClass"><chron>June 16, 2026</chron></span> /PRNewswire/ -- <a target="_blank" href="https://www.americannewsgroup.com/" target="_blank" rel="nofollow"><span>American News Group</span></a> News Commentary — There is a well-worn pattern in the life sciences: a company spends years on the science, goes public, and then — in the critical window right after listing — races to assemble the kind of leadership bench that can turn a http://www.streetinsider.com/Press+Releases/Fresh+Off+Its+Nasdaq+Debut%2C+a+Regenerative-Medicine+Upstart+Is+Stacking+Its+Board+With+Big-Pharma+Firepower/26650893.html Tue, 16 Jun 2026 08:15:00 -0400 2025 A.17530805 A.30162132 ABBV ABBV CNXU ESTA O.00384685 O.00391766 O.04998225 O.13747093 O.14731390 O.31243832 SN SNN SNN SYK SYK http://www.streetinsider.com/Press+Releases/Fresh+Off+Its+Nasdaq+Debut%2C+a+Regenerative-Medicine+Upstart+Is+Stacking+Its+Board+With+Big-Pharma+Firepower/26650893.html <div class="xn-content"> <p><i>Issued on behalf of <span value="NASDAQ-NMS:CNXU" idsrc="xmltag.org" >Conexeu Sciences Inc.</span></i></p><p><i>A clutch of new directors with Fortune 500 finance, M&amp;A, and aesthetics pedigrees signals that the newly public tissue-regeneration company is building for commercialization — in one of medicine's most consequential frontiers.</i></p><p><span class="legendSpanClass">RENO, Nev.</span>, <span class="legendSpanClass"><chron>June 16, 2026</chron></span> /PRNewswire/ -- <a target="_blank" href="https://www.americannewsgroup.com/" target="_blank" rel="nofollow"><span>American News Group</span></a> News Commentary — There is a well-worn pattern in the life sciences: a company spends years on the science, goes public, and then — in the critical window right after listing — races to assemble the kind of leadership bench that can turn a http://www.streetinsider.com/Press+Releases/Fresh+Off+Its+Nasdaq+Debut%2C+a+Regenerative-Medicine+Upstart+Is+Stacking+Its+Board+With+Big-Pharma+Firepower/26650893.html Tue, 16 Jun 2026 08:15:00 -0400 2025 A.17530805 A.30162132 ABBV ABBV CNXU ESTA O.00384685 O.00391766 O.04998225 O.13747093 O.14731390 O.31243832 SN SNN SNN SYK SYK http://www.streetinsider.com/Press+Releases/Fresh+Off+Its+Nasdaq+Debut%2C+a+Regenerative-Medicine+Upstart+Is+Stacking+Its+Board+With+Big-Pharma+Firepower/26650893.html <div class="xn-content"> <p><i>Issued on behalf of <span value="NASDAQ-NMS:CNXU" idsrc="xmltag.org" >Conexeu Sciences Inc.</span></i></p><p><i>A clutch of new directors with Fortune 500 finance, M&amp;A, and aesthetics pedigrees signals that the newly public tissue-regeneration company is building for commercialization — in one of medicine's most consequential frontiers.</i></p><p><span class="legendSpanClass">RENO, Nev.</span>, <span class="legendSpanClass"><chron>June 16, 2026</chron></span> /PRNewswire/ -- <a target="_blank" href="https://www.americannewsgroup.com/" target="_blank" rel="nofollow"><span>American News Group</span></a> News Commentary — There is a well-worn pattern in the life sciences: a company spends years on the science, goes public, and then — in the critical window right after listing — races to assemble the kind of leadership bench that can turn a http://www.streetinsider.com/Press+Releases/Fresh+Off+Its+Nasdaq+Debut%2C+a+Regenerative-Medicine+Upstart+Is+Stacking+Its+Board+With+Big-Pharma+Firepower/26650893.html Tue, 16 Jun 2026 08:15:00 -0400 2025 A.17530805 A.30162132 ABBV ABBV CNXU ESTA O.00384685 O.00391766 O.04998225 O.13747093 O.14731390 O.31243832 SN SNN SNN SYK SYK http://www.streetinsider.com/Press+Releases/Fresh+Off+Its+Nasdaq+Debut%2C+a+Regenerative-Medicine+Upstart+Is+Stacking+Its+Board+With+Big-Pharma+Firepower/26650893.html <div class="xn-content"> <p><i>Issued on behalf of <span value="NASDAQ-NMS:CNXU" idsrc="xmltag.org" >Conexeu Sciences Inc.</span></i></p><p><i>A clutch of new directors with Fortune 500 finance, M&amp;A, and aesthetics pedigrees signals that the newly public tissue-regeneration company is building for commercialization — in one of medicine's most consequential frontiers.</i></p><p><span class="legendSpanClass">RENO, Nev.</span>, <span class="legendSpanClass"><chron>June 16, 2026</chron></span> /PRNewswire/ -- <a target="_blank" href="https://www.americannewsgroup.com/" target="_blank" rel="nofollow"><span>American News Group</span></a> News Commentary — There is a well-worn pattern in the life sciences: a company spends years on the science, goes public, and then — in the critical window right after listing — races to assemble the kind of leadership bench that can turn a http://www.streetinsider.com/Press+Releases/Fresh+Off+Its+Nasdaq+Debut%2C+a+Regenerative-Medicine+Upstart+Is+Stacking+Its+Board+With+Big-Pharma+Firepower/26650893.html Tue, 16 Jun 2026 08:15:00 -0400 2025 A.17530805 A.30162132 ABBV ABBV CNXU ESTA O.00384685 O.00391766 O.04998225 O.13747093 O.14731390 O.31243832 SN SNN SNN SYK SYK http://www.streetinsider.com/Press+Releases/Fresh+Off+Its+Nasdaq+Debut%2C+a+Regenerative-Medicine+Upstart+Is+Stacking+Its+Board+With+Big-Pharma+Firepower/26650893.html <div class="xn-content"> <p><i>Issued on behalf of <span value="NASDAQ-NMS:CNXU" idsrc="xmltag.org" >Conexeu Sciences Inc.</span></i></p><p><i>A clutch of new directors with Fortune 500 finance, M&amp;A, and aesthetics pedigrees signals that the newly public tissue-regeneration company is building for commercialization — in one of medicine's most consequential frontiers.</i></p><p><span class="legendSpanClass">RENO, Nev.</span>, <span class="legendSpanClass"><chron>June 16, 2026</chron></span> /PRNewswire/ -- <a target="_blank" href="https://www.americannewsgroup.com/" target="_blank" rel="nofollow"><span>American News Group</span></a> News Commentary — There is a well-worn pattern in the life sciences: a company spends years on the science, goes public, and then — in the critical window right after listing — races to assemble the kind of leadership bench that can turn a http://www.streetinsider.com/Press+Releases/Fresh+Off+Its+Nasdaq+Debut%2C+a+Regenerative-Medicine+Upstart+Is+Stacking+Its+Board+With+Big-Pharma+Firepower/26650893.html Tue, 16 Jun 2026 08:15:00 -0400 2025 A.17530805 A.30162132 ABBV ABBV CNXU ESTA O.00384685 O.00391766 O.04998225 O.13747093 O.14731390 O.31243832 SN SNN SNN SYK SYK http://www.streetinsider.com/Press+Releases/Fresh+Off+Its+Nasdaq+Debut%2C+a+Regenerative-Medicine+Upstart+Is+Stacking+Its+Board+With+Big-Pharma+Firepower/26650893.html <div class="xn-content"> <p><i>Issued on behalf of <span value="NASDAQ-NMS:CNXU" idsrc="xmltag.org" >Conexeu Sciences Inc.</span></i></p><p><i>A clutch of new directors with Fortune 500 finance, M&amp;A, and aesthetics pedigrees signals that the newly public tissue-regeneration company is building for commercialization — in one of medicine's most consequential frontiers.</i></p><p><span class="legendSpanClass">RENO, Nev.</span>, <span class="legendSpanClass"><chron>June 16, 2026</chron></span> /PRNewswire/ -- <a target="_blank" href="https://www.americannewsgroup.com/" target="_blank" rel="nofollow"><span>American News Group</span></a> News Commentary — There is a well-worn pattern in the life sciences: a company spends years on the science, goes public, and then — in the critical window right after listing — races to assemble the kind of leadership bench that can turn a http://www.streetinsider.com/Press+Releases/Fresh+Off+Its+Nasdaq+Debut%2C+a+Regenerative-Medicine+Upstart+Is+Stacking+Its+Board+With+Big-Pharma+Firepower/26650893.html Tue, 16 Jun 2026 08:15:00 -0400 2025 A.17530805 A.30162132 ABBV ABBV CNXU ESTA O.00384685 O.00391766 O.04998225 O.13747093 O.14731390 O.31243832 SN SNN SNN SYK SYK http://www.streetinsider.com/Press+Releases/Fresh+Off+Its+Nasdaq+Debut%2C+a+Regenerative-Medicine+Upstart+Is+Stacking+Its+Board+With+Big-Pharma+Firepower/26650893.html <div class="xn-content"> <p><i>Issued on behalf of <span value="NASDAQ-NMS:CNXU" idsrc="xmltag.org" >Conexeu Sciences Inc.</span></i></p><p><i>A clutch of new directors with Fortune 500 finance, M&amp;A, and aesthetics pedigrees signals that the newly public tissue-regeneration company is building for commercialization — in one of medicine's most consequential frontiers.</i></p><p><span class="legendSpanClass">RENO, Nev.</span>, <span class="legendSpanClass"><chron>June 16, 2026</chron></span> /PRNewswire/ -- <a target="_blank" href="https://www.americannewsgroup.com/" target="_blank" rel="nofollow"><span>American News Group</span></a> News Commentary — There is a well-worn pattern in the life sciences: a company spends years on the science, goes public, and then — in the critical window right after listing — races to assemble the kind of leadership bench that can turn a http://www.streetinsider.com/Press+Releases/Fresh+Off+Its+Nasdaq+Debut%2C+a+Regenerative-Medicine+Upstart+Is+Stacking+Its+Board+With+Big-Pharma+Firepower/26650893.html Tue, 16 Jun 2026 08:15:00 -0400 2025 A.17530805 A.30162132 ABBV ABBV CNXU ESTA O.00384685 O.00391766 O.04998225 O.13747093 O.14731390 O.31243832 SN SNN SNN SYK SYK http://www.streetinsider.com/Press+Releases/Fresh+Off+Its+Nasdaq+Debut%2C+a+Regenerative-Medicine+Upstart+Is+Stacking+Its+Board+With+Big-Pharma+Firepower/26650893.html <div class="xn-content"> <p><i>Issued on behalf of <span value="NASDAQ-NMS:CNXU" idsrc="xmltag.org" >Conexeu Sciences Inc.</span></i></p><p><i>A clutch of new directors with Fortune 500 finance, M&amp;A, and aesthetics pedigrees signals that the newly public tissue-regeneration company is building for commercialization — in one of medicine's most consequential frontiers.</i></p><p><span class="legendSpanClass">RENO, Nev.</span>, <span class="legendSpanClass"><chron>June 16, 2026</chron></span> /PRNewswire/ -- <a target="_blank" href="https://www.americannewsgroup.com/" target="_blank" rel="nofollow"><span>American News Group</span></a> News Commentary — There is a well-worn pattern in the life sciences: a company spends years on the science, goes public, and then — in the critical window right after listing — races to assemble the kind of leadership bench that can turn a http://www.streetinsider.com/Press+Releases/Fresh+Off+Its+Nasdaq+Debut%2C+a+Regenerative-Medicine+Upstart+Is+Stacking+Its+Board+With+Big-Pharma+Firepower/26650893.html Tue, 16 Jun 2026 08:15:00 -0400 2025 A.17530805 A.30162132 ABBV ABBV CNXU ESTA O.00384685 O.00391766 O.04998225 O.13747093 O.14731390 O.31243832 SN SNN SNN SYK SYK http://www.streetinsider.com/Press+Releases/Fresh+Off+Its+Nasdaq+Debut%2C+a+Regenerative-Medicine+Upstart+Is+Stacking+Its+Board+With+Big-Pharma+Firepower/26650893.html <div class="xn-content"> <p><i>Issued on behalf of <span value="NASDAQ-NMS:CNXU" idsrc="xmltag.org" >Conexeu Sciences Inc.</span></i></p><p><i>A clutch of new directors with Fortune 500 finance, M&amp;A, and aesthetics pedigrees signals that the newly public tissue-regeneration company is building for commercialization — in one of medicine's most consequential frontiers.</i></p><p><span class="legendSpanClass">RENO, Nev.</span>, <span class="legendSpanClass"><chron>June 16, 2026</chron></span> /PRNewswire/ -- <a target="_blank" href="https://www.americannewsgroup.com/" target="_blank" rel="nofollow"><span>American News Group</span></a> News Commentary — There is a well-worn pattern in the life sciences: a company spends years on the science, goes public, and then — in the critical window right after listing — races to assemble the kind of leadership bench that can turn a http://www.streetinsider.com/Press+Releases/Fresh+Off+Its+Nasdaq+Debut%2C+a+Regenerative-Medicine+Upstart+Is+Stacking+Its+Board+With+Big-Pharma+Firepower/26650893.html Tue, 16 Jun 2026 08:15:00 -0400 2025 A.17530805 A.30162132 ABBV ABBV CNXU ESTA O.00384685 O.00391766 O.04998225 O.13747093 O.14731390 O.31243832 SN SNN SNN SYK SYK http://www.streetinsider.com/Press+Releases/Fresh+Off+Its+Nasdaq+Debut%2C+a+Regenerative-Medicine+Upstart+Is+Stacking+Its+Board+With+Big-Pharma+Firepower/26650893.html <div class="xn-content"> <p><i>Issued on behalf of <span value="NASDAQ-NMS:CNXU" idsrc="xmltag.org" >Conexeu Sciences Inc.</span></i></p><p><i>A clutch of new directors with Fortune 500 finance, M&amp;A, and aesthetics pedigrees signals that the newly public tissue-regeneration company is building for commercialization — in one of medicine's most consequential frontiers.</i></p><p><span class="legendSpanClass">RENO, Nev.</span>, <span class="legendSpanClass"><chron>June 16, 2026</chron></span> /PRNewswire/ -- <a target="_blank" href="https://www.americannewsgroup.com/" target="_blank" rel="nofollow"><span>American News Group</span></a> News Commentary — There is a well-worn pattern in the life sciences: a company spends years on the science, goes public, and then — in the critical window right after listing — races to assemble the kind of leadership bench that can turn a http://www.streetinsider.com/Press+Releases/Fresh+Off+Its+Nasdaq+Debut%2C+a+Regenerative-Medicine+Upstart+Is+Stacking+Its+Board+With+Big-Pharma+Firepower/26650893.html Tue, 16 Jun 2026 08:15:00 -0400 2025 A.17530805 A.30162132 ABBV ABBV CNXU ESTA O.00384685 O.00391766 O.04998225 O.13747093 O.14731390 O.31243832 SN SNN SNN SYK SYK http://www.streetinsider.com/Press+Releases/Fresh+Off+Its+Nasdaq+Debut%2C+a+Regenerative-Medicine+Upstart+Is+Stacking+Its+Board+With+Big-Pharma+Firepower/26650893.html <div class="xn-content"> <p><i>Issued on behalf of <span value="NASDAQ-NMS:CNXU" idsrc="xmltag.org" >Conexeu Sciences Inc.</span></i></p><p><i>A clutch of new directors with Fortune 500 finance, M&amp;A, and aesthetics pedigrees signals that the newly public tissue-regeneration company is building for commercialization — in one of medicine's most consequential frontiers.</i></p><p><span class="legendSpanClass">RENO, Nev.</span>, <span class="legendSpanClass"><chron>June 16, 2026</chron></span> /PRNewswire/ -- <a target="_blank" href="https://www.americannewsgroup.com/" target="_blank" rel="nofollow"><span>American News Group</span></a> News Commentary — There is a well-worn pattern in the life sciences: a company spends years on the science, goes public, and then — in the critical window right after listing — races to assemble the kind of leadership bench that can turn a http://www.streetinsider.com/Press+Releases/Fresh+Off+Its+Nasdaq+Debut%2C+a+Regenerative-Medicine+Upstart+Is+Stacking+Its+Board+With+Big-Pharma+Firepower/26650893.html Tue, 16 Jun 2026 08:15:00 -0400 2025 A.17530805 A.30162132 ABBV ABBV CNXU ESTA O.00384685 O.00391766 O.04998225 O.13747093 O.14731390 O.31243832 SN SNN SNN SYK SYK http://www.streetinsider.com/Press+Releases/Fresh+Off+Its+Nasdaq+Debut%2C+a+Regenerative-Medicine+Upstart+Is+Stacking+Its+Board+With+Big-Pharma+Firepower/26650893.html <div class="xn-content"> <p><i>Issued on behalf of <span value="NASDAQ-NMS:CNXU" idsrc="xmltag.org" >Conexeu Sciences Inc.</span></i></p><p><i>A clutch of new directors with Fortune 500 finance, M&amp;A, and aesthetics pedigrees signals that the newly public tissue-regeneration company is building for commercialization — in one of medicine's most consequential frontiers.</i></p><p><span class="legendSpanClass">RENO, Nev.</span>, <span class="legendSpanClass"><chron>June 16, 2026</chron></span> /PRNewswire/ -- <a target="_blank" href="https://www.americannewsgroup.com/" target="_blank" rel="nofollow"><span>American News Group</span></a> News Commentary — There is a well-worn pattern in the life sciences: a company spends years on the science, goes public, and then — in the critical window right after listing — races to assemble the kind of leadership bench that can turn a http://www.streetinsider.com/Press+Releases/Fresh+Off+Its+Nasdaq+Debut%2C+a+Regenerative-Medicine+Upstart+Is+Stacking+Its+Board+With+Big-Pharma+Firepower/26650893.html Tue, 16 Jun 2026 08:15:00 -0400 2025 A.17530805 A.30162132 ABBV ABBV CNXU ESTA O.00384685 O.00391766 O.04998225 O.13747093 O.14731390 O.31243832 SN SNN SNN SYK SYK http://www.streetinsider.com/Press+Releases/Fresh+Off+Its+Nasdaq+Debut%2C+a+Regenerative-Medicine+Upstart+Is+Stacking+Its+Board+With+Big-Pharma+Firepower/26650893.html <div class="xn-content"> <p><i>Issued on behalf of <span value="NASDAQ-NMS:CNXU" idsrc="xmltag.org" >Conexeu Sciences Inc.</span></i></p><p><i>A clutch of new directors with Fortune 500 finance, M&amp;A, and aesthetics pedigrees signals that the newly public tissue-regeneration company is building for commercialization — in one of medicine's most consequential frontiers.</i></p><p><span class="legendSpanClass">RENO, Nev.</span>, <span class="legendSpanClass"><chron>June 16, 2026</chron></span> /PRNewswire/ -- <a target="_blank" href="https://www.americannewsgroup.com/" target="_blank" rel="nofollow"><span>American News Group</span></a> News Commentary — There is a well-worn pattern in the life sciences: a company spends years on the science, goes public, and then — in the critical window right after listing — races to assemble the kind of leadership bench that can turn a http://www.streetinsider.com/Press+Releases/Fresh+Off+Its+Nasdaq+Debut%2C+a+Regenerative-Medicine+Upstart+Is+Stacking+Its+Board+With+Big-Pharma+Firepower/26650893.html Tue, 16 Jun 2026 08:15:00 -0400 2025 A.17530805 A.30162132 ABBV ABBV CNXU ESTA O.00384685 O.00391766 O.04998225 O.13747093 O.14731390 O.31243832 SN SNN SNN SYK SYK http://www.streetinsider.com/Press+Releases/Fresh+Off+Its+Nasdaq+Debut%2C+a+Regenerative-Medicine+Upstart+Is+Stacking+Its+Board+With+Big-Pharma+Firepower/26650893.html <div class="xn-content"> <p><i>Issued on behalf of <span value="NASDAQ-NMS:CNXU" idsrc="xmltag.org" >Conexeu Sciences Inc.</span></i></p><p><i>A clutch of new directors with Fortune 500 finance, M&amp;A, and aesthetics pedigrees signals that the newly public tissue-regeneration company is building for commercialization — in one of medicine's most consequential frontiers.</i></p><p><span class="legendSpanClass">RENO, Nev.</span>, <span class="legendSpanClass"><chron>June 16, 2026</chron></span> /PRNewswire/ -- <a target="_blank" href="https://www.americannewsgroup.com/" target="_blank" rel="nofollow"><span>American News Group</span></a> News Commentary — There is a well-worn pattern in the life sciences: a company spends years on the science, goes public, and then — in the critical window right after listing — races to assemble the kind of leadership bench that can turn a http://www.streetinsider.com/Press+Releases/Fresh+Off+Its+Nasdaq+Debut%2C+a+Regenerative-Medicine+Upstart+Is+Stacking+Its+Board+With+Big-Pharma+Firepower/26650893.html Tue, 16 Jun 2026 08:15:00 -0400 2025 A.17530805 A.30162132 ABBV ABBV CNXU ESTA O.00384685 O.00391766 O.04998225 O.13747093 O.14731390 O.31243832 SN SNN SNN SYK SYK http://www.streetinsider.com/Press+Releases/Fresh+Off+Its+Nasdaq+Debut%2C+a+Regenerative-Medicine+Upstart+Is+Stacking+Its+Board+With+Big-Pharma+Firepower/26650893.html <div class="xn-content"> <p><i>Issued on behalf of <span value="NASDAQ-NMS:CNXU" idsrc="xmltag.org" >Conexeu Sciences Inc.</span></i></p><p><i>A clutch of new directors with Fortune 500 finance, M&amp;A, and aesthetics pedigrees signals that the newly public tissue-regeneration company is building for commercialization — in one of medicine's most consequential frontiers.</i></p><p><span class="legendSpanClass">RENO, Nev.</span>, <span class="legendSpanClass"><chron>June 16, 2026</chron></span> /PRNewswire/ -- <a target="_blank" href="https://www.americannewsgroup.com/" target="_blank" rel="nofollow"><span>American News Group</span></a> News Commentary — There is a well-worn pattern in the life sciences: a company spends years on the science, goes public, and then — in the critical window right after listing — races to assemble the kind of leadership bench that can turn a http://www.streetinsider.com/Press+Releases/Fresh+Off+Its+Nasdaq+Debut%2C+a+Regenerative-Medicine+Upstart+Is+Stacking+Its+Board+With+Big-Pharma+Firepower/26650893.html Tue, 16 Jun 2026 08:15:00 -0400 2025 A.17530805 A.30162132 ABBV ABBV CNXU ESTA O.00384685 O.00391766 O.04998225 O.13747093 O.14731390 O.31243832 SN SNN SNN SYK SYK http://www.streetinsider.com/PRNewswire/Fresh+Off+Its+Nasdaq+Debut%2C+a+Regenerative-Medicine+Upstart+Is+Stacking+Its+Board+With+Big-Pharma+Firepower/26650893.html <div class="xn-content"> <p><i>Issued on behalf of <span value="NASDAQ-NMS:CNXU" idsrc="xmltag.org" >Conexeu Sciences Inc.</span></i></p><p><i>A clutch of new directors with Fortune 500 finance, M&amp;A, and aesthetics pedigrees signals that the newly public tissue-regeneration company is building for commercialization — in one of medicine's most consequential frontiers.</i></p><p><span class="legendSpanClass">RENO, Nev.</span>, <span class="legendSpanClass"><chron>June 16, 2026</chron></span> /PRNewswire/ -- <a target="_blank" href="https://www.americannewsgroup.com/" target="_blank" rel="nofollow"><span>American News Group</span></a> News Commentary — There is a well-worn pattern in the life sciences: a company spends years on the science, goes public, and then — in the critical window right after listing — races to assemble the kind of leadership bench that can turn a http://www.streetinsider.com/PRNewswire/Fresh+Off+Its+Nasdaq+Debut%2C+a+Regenerative-Medicine+Upstart+Is+Stacking+Its+Board+With+Big-Pharma+Firepower/26650893.html Tue, 16 Jun 2026 08:15:00 -0400 2025 A.17530805 A.30162132 ABBV ABBV CNXU ESTA O.00384685 O.00391766 O.04998225 O.13747093 O.14731390 O.31243832 SN SNN SNN SYK SYK http://www.streetinsider.com/PRNewswire/Fresh+Off+Its+Nasdaq+Debut%2C+a+Regenerative-Medicine+Upstart+Is+Stacking+Its+Board+With+Big-Pharma+Firepower/26650893.html <div class="xn-content"> <p><i>Issued on behalf of <span value="NASDAQ-NMS:CNXU" idsrc="xmltag.org" >Conexeu Sciences Inc.</span></i></p><p><i>A clutch of new directors with Fortune 500 finance, M&amp;A, and aesthetics pedigrees signals that the newly public tissue-regeneration company is building for commercialization — in one of medicine's most consequential frontiers.</i></p><p><span class="legendSpanClass">RENO, Nev.</span>, <span class="legendSpanClass"><chron>June 16, 2026</chron></span> /PRNewswire/ -- <a target="_blank" href="https://www.americannewsgroup.com/" target="_blank" rel="nofollow"><span>American News Group</span></a> News Commentary — There is a well-worn pattern in the life sciences: a company spends years on the science, goes public, and then — in the critical window right after listing — races to assemble the kind of leadership bench that can turn a http://www.streetinsider.com/PRNewswire/Fresh+Off+Its+Nasdaq+Debut%2C+a+Regenerative-Medicine+Upstart+Is+Stacking+Its+Board+With+Big-Pharma+Firepower/26650893.html Tue, 16 Jun 2026 08:15:00 -0400 2025 A.17530805 A.30162132 ABBV ABBV CNXU ESTA O.00384685 O.00391766 O.04998225 O.13747093 O.14731390 O.31243832 SN SNN SNN SYK SYK http://www.streetinsider.com/PRNewswire/Fresh+Off+Its+Nasdaq+Debut%2C+a+Regenerative-Medicine+Upstart+Is+Stacking+Its+Board+With+Big-Pharma+Firepower/26650893.html <div class="xn-content"> <p><i>Issued on behalf of <span value="NASDAQ-NMS:CNXU" idsrc="xmltag.org" >Conexeu Sciences Inc.</span></i></p><p><i>A clutch of new directors with Fortune 500 finance, M&amp;A, and aesthetics pedigrees signals that the newly public tissue-regeneration company is building for commercialization — in one of medicine's most consequential frontiers.</i></p><p><span class="legendSpanClass">RENO, Nev.</span>, <span class="legendSpanClass"><chron>June 16, 2026</chron></span> /PRNewswire/ -- <a target="_blank" href="https://www.americannewsgroup.com/" target="_blank" rel="nofollow"><span>American News Group</span></a> News Commentary — There is a well-worn pattern in the life sciences: a company spends years on the science, goes public, and then — in the critical window right after listing — races to assemble the kind of leadership bench that can turn a http://www.streetinsider.com/PRNewswire/Fresh+Off+Its+Nasdaq+Debut%2C+a+Regenerative-Medicine+Upstart+Is+Stacking+Its+Board+With+Big-Pharma+Firepower/26650893.html Tue, 16 Jun 2026 08:15:00 -0400 2025 A.17530805 A.30162132 ABBV ABBV CNXU ESTA O.00384685 O.00391766 O.04998225 O.13747093 O.14731390 O.31243832 SN SNN SNN SYK SYK http://www.streetinsider.com/PRNewswire/Fresh+Off+Its+Nasdaq+Debut%2C+a+Regenerative-Medicine+Upstart+Is+Stacking+Its+Board+With+Big-Pharma+Firepower/26650893.html <div class="xn-content"> <p><i>Issued on behalf of <span value="NASDAQ-NMS:CNXU" idsrc="xmltag.org" >Conexeu Sciences Inc.</span></i></p><p><i>A clutch of new directors with Fortune 500 finance, M&amp;A, and aesthetics pedigrees signals that the newly public tissue-regeneration company is building for commercialization — in one of medicine's most consequential frontiers.</i></p><p><span class="legendSpanClass">RENO, Nev.</span>, <span class="legendSpanClass"><chron>June 16, 2026</chron></span> /PRNewswire/ -- <a target="_blank" href="https://www.americannewsgroup.com/" target="_blank" rel="nofollow"><span>American News Group</span></a> News Commentary — There is a well-worn pattern in the life sciences: a company spends years on the science, goes public, and then — in the critical window right after listing — races to assemble the kind of leadership bench that can turn a http://www.streetinsider.com/PRNewswire/Fresh+Off+Its+Nasdaq+Debut%2C+a+Regenerative-Medicine+Upstart+Is+Stacking+Its+Board+With+Big-Pharma+Firepower/26650893.html Tue, 16 Jun 2026 08:15:00 -0400 2025 A.17530805 A.30162132 ABBV ABBV CNXU ESTA O.00384685 O.00391766 O.04998225 O.13747093 O.14731390 O.31243832 SN SNN SNN SYK SYK http://www.streetinsider.com/PRNewswire/Fresh+Off+Its+Nasdaq+Debut%2C+a+Regenerative-Medicine+Upstart+Is+Stacking+Its+Board+With+Big-Pharma+Firepower/26650893.html <div class="xn-content"> <p><i>Issued on behalf of <span value="NASDAQ-NMS:CNXU" idsrc="xmltag.org" >Conexeu Sciences Inc.</span></i></p><p><i>A clutch of new directors with Fortune 500 finance, M&amp;A, and aesthetics pedigrees signals that the newly public tissue-regeneration company is building for commercialization — in one of medicine's most consequential frontiers.</i></p><p><span class="legendSpanClass">RENO, Nev.</span>, <span class="legendSpanClass"><chron>June 16, 2026</chron></span> /PRNewswire/ -- <a target="_blank" href="https://www.americannewsgroup.com/" target="_blank" rel="nofollow"><span>American News Group</span></a> News Commentary — There is a well-worn pattern in the life sciences: a company spends years on the science, goes public, and then — in the critical window right after listing — races to assemble the kind of leadership bench that can turn a http://www.streetinsider.com/PRNewswire/Fresh+Off+Its+Nasdaq+Debut%2C+a+Regenerative-Medicine+Upstart+Is+Stacking+Its+Board+With+Big-Pharma+Firepower/26650893.html Tue, 16 Jun 2026 08:15:00 -0400 2025 A.17530805 A.30162132 ABBV ABBV CNXU ESTA O.00384685 O.00391766 O.04998225 O.13747093 O.14731390 O.31243832 SN SNN SNN SYK SYK http://www.streetinsider.com/PRNewswire/Fresh+Off+Its+Nasdaq+Debut%2C+a+Regenerative-Medicine+Upstart+Is+Stacking+Its+Board+With+Big-Pharma+Firepower/26650893.html <div class="xn-content"> <p><i>Issued on behalf of <span value="NASDAQ-NMS:CNXU" idsrc="xmltag.org" >Conexeu Sciences Inc.</span></i></p><p><i>A clutch of new directors with Fortune 500 finance, M&amp;A, and aesthetics pedigrees signals that the newly public tissue-regeneration company is building for commercialization — in one of medicine's most consequential frontiers.</i></p><p><span class="legendSpanClass">RENO, Nev.</span>, <span class="legendSpanClass"><chron>June 16, 2026</chron></span> /PRNewswire/ -- <a target="_blank" href="https://www.americannewsgroup.com/" target="_blank" rel="nofollow"><span>American News Group</span></a> News Commentary — There is a well-worn pattern in the life sciences: a company spends years on the science, goes public, and then — in the critical window right after listing — races to assemble the kind of leadership bench that can turn a http://www.streetinsider.com/PRNewswire/Fresh+Off+Its+Nasdaq+Debut%2C+a+Regenerative-Medicine+Upstart+Is+Stacking+Its+Board+With+Big-Pharma+Firepower/26650893.html Tue, 16 Jun 2026 08:15:00 -0400 2025 A.17530805 A.30162132 ABBV ABBV CNXU ESTA O.00384685 O.00391766 O.04998225 O.13747093 O.14731390 O.31243832 SN SNN SNN SYK SYK http://www.streetinsider.com/PRNewswire/Fresh+Off+Its+Nasdaq+Debut%2C+a+Regenerative-Medicine+Upstart+Is+Stacking+Its+Board+With+Big-Pharma+Firepower/26650893.html <div class="xn-content"> <p><i>Issued on behalf of <span value="NASDAQ-NMS:CNXU" idsrc="xmltag.org" >Conexeu Sciences Inc.</span></i></p><p><i>A clutch of new directors with Fortune 500 finance, M&amp;A, and aesthetics pedigrees signals that the newly public tissue-regeneration company is building for commercialization — in one of medicine's most consequential frontiers.</i></p><p><span class="legendSpanClass">RENO, Nev.</span>, <span class="legendSpanClass"><chron>June 16, 2026</chron></span> /PRNewswire/ -- <a target="_blank" href="https://www.americannewsgroup.com/" target="_blank" rel="nofollow"><span>American News Group</span></a> News Commentary — There is a well-worn pattern in the life sciences: a company spends years on the science, goes public, and then — in the critical window right after listing — races to assemble the kind of leadership bench that can turn a http://www.streetinsider.com/PRNewswire/Fresh+Off+Its+Nasdaq+Debut%2C+a+Regenerative-Medicine+Upstart+Is+Stacking+Its+Board+With+Big-Pharma+Firepower/26650893.html Tue, 16 Jun 2026 08:15:00 -0400 2025 A.17530805 A.30162132 ABBV ABBV CNXU ESTA O.00384685 O.00391766 O.04998225 O.13747093 O.14731390 O.31243832 SN SNN SNN SYK SYK